SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Zentek Ltd.
ZEN.V 1.020+7.4%Dec 18 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Canseco
George69
ValuHunter
From: Candu12/10/2025 6:27:49 PM
3 Recommendations   of 54339
 
Is anyone at McMaster University working with Graphene oxide for a delivery system including for cancer treatment

ChatGPT said:

Thought for 17s

Short answer: Yes. McMaster researchers (faculty groups and graduate students) are working with graphene/graphene-oxide (GO/rGO) in a variety of projects — including biosensing, functionalization, pH-responsive behaviour and nanocarriers — and some of that work is explicitly tied to drug-delivery concepts that are applicable to cancer therapy. PubMed+2chemistry.mcmaster.ca+2

Who / where (examples and evidence)

  • Li lab (Biochemistry & Biomedical Sciences) — published an rGO + aptamer biosensor platform (shows McMaster expertise combining reduced-graphene-oxide and biological delivery/recognition systems). This group (Dr. Yingfu Li) works on nucleic-acid/aptamer technologies that intersect with graphene materials. PubMed

  • Kruse Research Group (Chemistry / surface science) — active on graphene derivatives (GO/rGO), defect engineering and pH-responsive behaviour that are relevant for designing GO-based delivery systems (for example, pH-responsive release in tumour microenvironments). chemistry.mcmaster.ca+1

  • Other McMaster theses / student projects — several graduate theses and student projects at McMaster reference graphene oxide used in sensor and delivery-style nanomaterials (macsphere institutional repository). These indicate ongoing lab/student work that uses GO for biomedical/analytical applications. macsphere.mcmaster.ca+1

Context (why this matters)

  • Graphene oxide and its functionalized derivatives are widely studied as drug/gene carriers because of large surface area, easy functionalization and pH/triggerable chemistries; McMaster groups are publishing on the materials and bio-interface aspects that are the building blocks for GO drug-delivery systems. If your interest is specifically GO nanoparticles used in preclinical cancer therapy (in-vivo delivery + animal efficacy), McMaster papers more often address materials, sensing and in-vitro functionalization; translation to in-vivo cancer delivery is less commonly shown in McMaster’s open literature so far (many GO?cancer delivery demonstrations are in the broader literature). MDPI+1

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext